MedCity News December 22, 2024
Marissa Plescia

Walgreens is reportedly exploring selling itself to private equity firm Sycamore Partners. It might be the right decision for the company, some experts say.

Is anyone surprised that Walgreens is looking to sell itself — reportedly to private equity firm Sycamore Partners?

Walgreens has been losing a lot of greenbacks lately: a whopping $8.6 billion of them in fiscal 2024. Its foray into primary care has been a challenge forcing it to close a series of VillageMD clinics nationwide. Even its pharmacy business has faced competition from nimble, online pharmacy retailers like Amazon Pharmacy and Mark Cuban’s Cost Plus Drugs and fallen casualty to drug prices being negotiated.

And investors have paid attention to its missteps. Over the past five...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Pharma, Pharma / Biotech
Related Articles:
Why 2025 Could Be A Good Reimbursement Year For CVS And Walgreens
PBM reform dropped in Congress' funding package
2025 and Beyond: Key Trends to Watch in Pharmacy
U.S. Health Care Spending Reaches $4.9 Trillion
Mark Cuban: A Master Disrupter for American Healthcare

Share This Article